The global Mucopolysaccharidosis syndrome therapeutics market is observing significant development fueled by an rising prevalence of the illness worldwide. Early diagnosis and accessibility of effective treatments are key influences propelling market progress. The market is categorized based on therapy type, disease severity, and geographical regi